Pfizer Unit's Alleged Drug Supply Cuts Aren't Anticompetitive
By Dorothy Atkins ( January 6, 2020, 9:22 PM EST) -- A New York federal judge on Monday tossed Apotex Corp.'s antitrust claims alleging that Pfizer subsidiary Hospira Inc. broke their exclusive agreement and cut off its supply for the generic antibiotic cefepime to form a monopoly, finding that the subsidiary never held market power and that the claims are merely a "re-casting" of state contract claims....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.